The role of pulmonary infection in pediatric asthma

Allergy and Asthma Proceedings

Volumn 28, Issue 2, 2007, Pages 190-193

  Brunetti, Luigia ^a,b   Colazzo, Damiano ^a,b   Francavilla, Ruggiero ^a,b   Tesse, Riccardina ^a,b   De Sario, Valeria ^a,b   Lorè, Maria ^a,b   Armenio, Lucio ^a,b  

^a University of Bari ^*

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Asthma; Bronchiolitis; Childhood; Chlamydia pneumoniae; Cytokines; Infections; Interleukins; Mycoplasma pneumoniae; Respiratory syncytial virus

Indexed keywords

CYTOKINE;

ABNORMAL RESPIRATORY SOUND; ACUTE DISEASE; ANTIBODY PRODUCTION; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CHILD; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MYCOPLASMA PNEUMONIA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIROLOGY;

ACUTE DISEASE; ANTIBODY FORMATION; ASTHMA; CHILD; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; PNEUMONIA, MYCOPLASMA; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS;

EID: 34248402465     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2964     Document Type: Article

References (53)

1. Gern JE, and Lemanske RF. Infectious triggers of pediatric asthma. Pediatr Clin North Am 50:555, 2003.
2. De Martino M, and Vierucci A. Infezioni virali delle vie aeree ed asma. In Allergologia Pediatrica. Vierucci A (Ed). Selecta Medica: Pavia, Italy, 71-84, 2003.
3. Openshaw PJM. Immunological mechanism in respiratory syncytial virus disease. Springer Semin Immunopathol 17:187, 1995.
4. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 332:133, 1995.
5. Jackson M, and Scott R. Different patterns of cytokine induction in cultures of respiratory syncityal (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins. J Med Virol 49:161,1996.
6. Tekkanat KK, Maassab HF, Cho DS, et al. IL-13-induced airway hyperreactivity during respiratory syncityal virus infection is STAT6 dependent. J Immunol 166:3542, 2001.
7. Kurt-Jones EA, Popola L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398, 2000.
8. Kaul P, Biagioli MC, Singh I, et al. Rhinovirus-induced oxidative stress and interleukin-8 elaboration involves p47-phox but is independent of attachment to intercellular adhesion molecole-1 and viral replication. J Infect Dis 181:1885, 2000.
9. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like-receptor 3. Nature 413:732, 2001.
10. Williams BRG. PKR: A sentinel kinase for cellular stress. Oncogene 18:6112, 1999.
11. Sanders SP. Asthma, viruses, and nitric oxide. Proc Soc Exp Biol Med 220:123, 1999.
12. Message SD, and Johnston SL. Host defense function of the airway epithelium in health and disease: Clinical background. J Leukoc Biol 75:5, 2004.
13. Gern JE, Vrtis R, Kelly EAB, et al. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 157:1605, 1996.
14. Panuska JR, Merolla R, Rebert NA, et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implication for incomplete immunity. J Clin Invest 96:2445, 1995.
15. Johnston SL, Papi A, Monick MM, et al. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 175:323, 1997.
16. Cardell LO, Agusti C, Takeyama K, et al. LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. Am J Respir Crit Care Med 160:411, 1999.
17. 1 expression in Brown Norway rats. Am J Respir Crit Care Med 154:1834, 1996.
18. Dosanjh A, Rednam S, and Martin M. Respiratory syncytial virus augments production of fibroblast growth factor basic in vitro: Implications for a possible mechanism of prolonged wheezing after infection. Pediatr Allergy Immunol 14:437, 2003.
19. Lee CG, Yoon HJ, Khu Z, et al. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 23:662, 2000.
20. Gern JE, Rosenthal LA, Sorkness LR, et al. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 115:668, 2005.
21. Murray M, Webb MS, O'Callaghan C, et al. Respiratory status and allergy after bronchiolitis. Arch Dis Child 67:482, 1992.
22. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syrtcytial virus in early life and risk of wheezy and allergy by age 13 years. Lancet 354:541, 1999.
23. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics 95:500, 1995.
24. Welliver RC. Immunologic mechanism of virus-induced wheezing and asthma. J Pediatr 135:814, 1999.
25. Garofalo R, Kimpen JLL, Welliver RC, et al. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 120:28, 1992.
26. Tsutsumi H, Matsuda K, Sone S, et al. Respiratory syncytial virus-induced cytokine production by neonatal macrophages. Clin Exp Immunol 106:442, 1996.
27. Patel JA, Kunimoto M, Sim TC, et al. Interleukin-1α mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol 13:602, 1995.
28. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbation of asthma in 9-11 year old children. BMJ 310:1225, 1995.
29. Nicholson KG, Kent J, and Ireland DC. Respiratory viruses and exacerbation of asthma in adults. BMJ 307:982, 1993.
30. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: A rime trend analysis. Am J Respir Crit Care Med 154:654, 1996.
31. Rakes JP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: IgE and eosinophil analyses. Am J Respir Crit Care Med 159:785, 1999.
32. Doyle WJ, Skoner DP, Fireman P, et al. Rhinovirus 39 infection in allergic and non allergic subjects. J Allergy Clin Immunol 89:968, 1992.
33. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatics and non asthmatic individuals: A longitudinal cohort study. Lancet 359:831, 2002.
34. Green RM, Cusotvic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: Case-control study. BMJ 324:763, 2002.
35. Tarlo SM, Broder I, Corey P, et al. The role of symptomatic colds in asthma exacerbations: Influence of outdoor allergenes and air pollutants. J Allergy Clin Immunol 108:52, 2001.
36. Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 23:878, 2004.
37. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158:998, 1998.
38. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107:595, 2001.
39. Von Hertzen LC. Role of persistent infection in the control and severity of asthma: Focus on Chlamydia pneumoniae. Eur Respir J 19:546, 2002.
40. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 16:1142, 2000.
41. Thumerelle C, Deschildre A, Bouquillon C, et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: A prospective study in the Nord-Pasde Calais region (France). Pediatr Pulmonol 35:75, 2003.
42. Chu HW, Kraft M, Krause J, et al. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 106:713, 2000.
43. Strachan DP. Hay fever, hygiene, and household size. BMJ 299:1259, 1989.
44. Hansbro PM, Beagley KW, Horvat JC, et al. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 101:193, 2004.
45. Gaydos GA, Summersgill JT, Sahany NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614, 1996.
46. Morrison RP. Persistent Chlamydia trachomatis infection: In vitro phenomenon or in vivo trigger of reactive arthritis? J Rheumatol 25:610, 1998.
47. Young RA, and Elliott TJ. Stress proteins, infection, and immune surveillance. Cell 59:5, 1989.
48. Morrison RP. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Semin Immunol 3:25, 1991.
49. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21:215, 1996.
50. Von Hertzen LC. Role of persistent infection in the control and severity of asthma: Focus on Chlamydia pneumoniae. Eur Respir J 19:546, 2002.
51. Coombes BK, Johnson DL, and Mahony JB. Strategic targeting of essential host-pathogen interactions in chlamydial disease. Curr Drug Targets Infect Disord 2:201, 2002.
52. Hahn DL. Chlamydia pneumoniae, asthma, and COPD: What is the evidence? Ann Allergy Asthma Immunol 83:271, 1999.
53. Cunningham AF, Johnston SL, Julious SA, et al. Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 11:345, 1998.